The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Pharmacological Activation of Pyruvate Kinase M2 Inhibits CD4+ T Cell Pathogenicity and Suppresses Autoimmunity
Open accessAbstract
Pyruvate kinase (PK) catalyzes the conversion of phosphoenolpyruvate to pyruvate during glycolysis. The PK isoform PKM2 has additional roles in regulation of gene transcription and protein phosphorylation. PKM2 has been shown to control macrophage metabolic remodeling in inflammation, but its role in T cell biology is poorly understood. Here, we report PKM2 upregulation, phosphorylation, and nuclear accumulation in murine and human CD4 + T cells following activation in vitro . Treatment of T cells with TEPP-46, an allosteric activator that induces PKM2 tetramerization and blocks its nuclear translocation, strongly reduces their activation, proliferation, and cytokine production by inhibiting essential signaling pathways and thus preventing the engagement of glycolysis. TEPP-46 limits the development of both T helper 17 (Th17) and Th1 cells in vitro and ameliorates experimental autoimmune encephalomyelitis (EAE) in vivo . Overall, our results suggest that pharmacological targeting of PKM2 may represent a valuable therapeutic approach in T cell-mediated inflammation and autoimmunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Csibi, A., Lee, G., Yoon, S.-O., Tong, H., Ilter, D., Elia, I., Fendt, S.-M., Roberts, T. M., & Blenis, J. (2014) · Current Biology · doi:10.1016/j.cub.2014.08.007 · Cited by 256
RetractedModerated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
Liao, Y., Smyth, G. K., & Shi, W. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt656 · Cited by 27,219
A guide to immunometabolism for immunologists
O'Neill, L. A. J., Kishton, R. J., & Rathmell, J. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.70 · Cited by 3,315
Self-citationThe transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation
Wang, R., Dillon, C. P., Shi, L. Z., Milasta, S., Carter, R., Finkelstein, D., McCormick, L. L., Fitzgerald, P., Chi, H., Munger, J., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.09.021 · Cited by 2,140 · cited 3×
“Previous work has shown that, upon TCR activation, T cells upregulate PKM2 expression (Wang et al., 2011; Cao et al., 2014).”
BackgroundActivation of a metabolic gene regulatory network downstream of mTOR complex 1
Düvel, K., Yecies, J. L., Menon, S., Raman, P., Lipovsky, A. I., Souza, A. L., Triantafellow, E., Ma, Q., Gorski, R., Cleaver, S., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.06.022 · Cited by 2,020
Shi, L. Z., Wang, R., Huang, G., Vogel, P., Neale, G., Green, D. R., & Chi, H. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110278 · Cited by 1,803
Metabolic Pathways in Immune Cell Activation and Quiescence
Pearce, E. L., & Pearce, E. J. (2013) · Immunity · doi:10.1016/j.immuni.2013.04.005 · Cited by 1,692 · cited 2×
“Both innate and adaptive immune cells undergo substantial metabolic reprogramming following activation (Pearce and Pearce, 2013; O’Neill et al., 2016).”
BackgroundInfluentialSelf-citationControl of TH17/Treg Balance by Hypoxia-Inducible Factor 1
Dang, E. V., Barbi, J., Yang, H.-Y., Jinasena, D., Yu, H., Zheng, Y., Bordman, Z., Fu, J., Kim, Y., Yen, H.-R., et al. (2011) · Cell · doi:10.1016/j.cell.2011.07.033 · Cited by 1,595 · cited 3×
“Of note, previous work showed that inhibition of mTORC1, Myc, and HIF-1a all induce the development of Foxp3+ T cells under inflammatory conditions, mainly by blocking the engagement of glycolysis (Wei et al., 2016; Shi et al., 2011; Dang et al., 2011; Feldhoff et al., 2017).”
Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1
Luo, W., Hu, H., Chang, R., Zhong, J., Knabel, M., O'Meally, R., Cole, R. N., Pandey, A., & Semenza, G. L. (2011) · Cell · doi:10.1016/j.cell.2011.03.054 · Cited by 1,463
Palsson-McDermott, E. M., Curtis, A. M., Goel, G., Lauterbach, M. A. R., Sheedy, F. J., Gleeson, L. E., van den Bosch, M. W. M., Quinn, S. R., Domingo-Fernandez, R., Johnston, D. G. W., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2014.12.005 · Cited by 1,397
Self-citationThe mTOR Kinase Differentially Regulates Effector and Regulatory T Cell Lineage Commitment
Delgoffe, G. M., Kole, T. P., Zheng, Y., Zarek, P. E., Matthews, K. L., Xiao, B., Worley, P. F., Kozma, S. C., & Powell, J. D. (2009) · Immunity · doi:10.1016/j.immuni.2009.04.014 · Cited by 1,284
Macintyre, A. N., Gerriets, V. A., Nichols, A. G., Michalek, R. D., Rudolph, M. C., Deoliveira, D., Anderson, S. M., Abel, E. D., Chen, B. J., Hale, L. P., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.05.004 · Cited by 1,127
ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect
Yang, W., Zheng, Y., Xia, Y., Ji, H., Chen, X., Guo, F., Lyssiotis, C. A., Aldape, K., Cantley, L. C., & Lu, Z. (2012) · Nature Cell Biology · doi:10.1038/ncb2629 · Cited by 918
PKM2 Phosphorylates Histone H3 and Promotes Gene Transcription and Tumorigenesis
Yang, W., Xia, Y., Hawke, D., Li, X., Liang, J., Xing, D., Aldape, K., Hunter, T., Alfred Yung, W. K., & Lu, Z. (2012) · Cell · doi:10.1016/j.cell.2012.07.018 · Cited by 846
Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis
Anastasiou, D., Yu, Y., Israelsen, W. J., Jiang, J.-K., Boxer, M. B., Hong, B. S., Tempel, W., Dimov, S., Shen, M., Jha, A., et al. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.1060 · Cited by 816
Unraveling the Complex Interplay Between T Cell Metabolism and Function
Klein Geltink, R. I., Kyle, R. L., & Pearce, E. L. (2018) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042617-053019 · Cited by 814
Self-citationmTORC1 couples immune signals and metabolic programming to establish Treg-cell function
Zeng, H., Yang, K., Cloer, C., Neale, G., Vogel, P., & Chi, H. (2013) · Nature · doi:10.1038/nature12297 · Cited by 788
Tyrosine Phosphorylation Inhibits PKM2 to Promote the Warburg Effect and Tumor Growth
Hitosugi, T., Kang, S., Vander Heiden, M. G., Chung, T.-W., Elf, S., Lythgoe, K., Dong, S., Lonial, S., Wang, X., Chen, G. Z., et al. (2009) · Science Signaling · doi:10.1126/scisignal.2000431 · Cited by 784 · cited 1×
“Of note, at all stages of activation, a significant proportion of PKM2 was found to be phosphorylated on tyrosine 105 (Y105), a modification that is known to limit the formation of the PKM2 tetrameric isoform (Figure 1C) (Prakasam et al., 2018; Hitosugi et al., 2009).”
BackgroundPyruvate Kinase M2 Regulates Gene Transcription by Acting as a Protein Kinase
Gao, X., Wang, H., Yang, J. J., Liu, X., & Liu, Z.-R. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.01.001 · Cited by 772
The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells
Seif, F., Khoshmirsafa, M., Aazami, H., Mohsenzadegan, M., Sedighi, G., & Bahar, M. (2017) · Cell Communication and Signaling · doi:10.1186/s12964-017-0177-y · Cited by 768
Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation
Gerriets, V. A., Kishton, R. J., Nichols, A. G., Macintyre, A. N., Inoue, M., Ilkayeva, O., Winter, P. S., Liu, X., Priyadharshini, B., Slawinska, M. E., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76012 · Cited by 731
Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity
Kornberg, M. D., Bhargava, P., Kim, P. M., Putluri, V., Snowman, A. M., Putluri, N., Calabresi, P. A., & Snyder, S. H. (2018) · Science · doi:10.1126/science.aan4665 · Cited by 687
FELASA working group on revision of guidelines for health monitoring of rodents and rabbits, Mähler (Convenor), M., Berard, M., Feinstein, R., Gallagher, A., Illgen-Wilcke, B., Pritchett-Corning, K., & Raspa, M. (2014) · Laboratory Animals · doi:10.1177/0023677213516312 · Cited by 646
Pyruvate kinase: Function, regulation and role in cancer
Israelsen, W. J., & Vander Heiden, M. G. (2015) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2015.08.004 · Cited by 589
Clambey, E. T., McNamee, E. N., Westrich, J. A., Glover, L. E., Campbell, E. L., Jedlicka, P., de Zoeten, E. F., Cambier, J. C., Stenmark, K. R., Colgan, S. P., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202366109 · Cited by 560 · cited 1×
“generation of Tregs, especially in vivo (Clambey et al., 2012; Zeng et al., 2013; Wu et al., 2014; Procaccini et al., 2016).”
PKM2, cancer metabolism, and the road ahead
Dayton, T. L., Jacks, T., & Vander Heiden, M. G. (2016) · The EMBO Reports · doi:10.15252/embr.201643300 · Cited by 515 · cited 2×
“PKM2 is mainly present as a monomer/dimer in tissues with anabolic functions, including proliferating cells and cancer cells, and is subject to complex allosteric regulation that controls its enzymatic activity (Israelsen and Vander Heiden, 2015; Dong et al., 2016; Dayton et al., 2016).”
BackgroundWei, J., Long, L., Yang, K., Guy, C., Shrestha, S., Chen, Z., Wu, C., Vogel, P., Neale, G., Green, D. R., et al. (2016) · Nature Immunology · doi:10.1038/ni.3365 · Cited by 470
Ye, J., Mancuso, A., Tong, X., Ward, P. S., Fan, J., Rabinowitz, J. D., & Thompson, C. B. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1204176109 · Cited by 410
Aerobic glycolysis during lymphocyte proliferation
WANG, T., MARQUARDT, C., & FOKER, J. (1976) · Nature · doi:10.1038/261702a0 · Cited by 334
PKM2 and cancer: The function of PKM2 beyond glycolysis
DONG, G., MAO, Q., XIA, W., XU, Y., WANG, J., XU, L., & JIANG, F. (2016) · Oncology Letters · doi:10.3892/ol.2016.4168 · Cited by 325
Procaccini, C., Carbone, F., Di Silvestre, D., Brambilla, F., De Rosa, V., Galgani, M., Faicchia, D., Marone, G., Tramontano, D., Corona, M., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.01.028 · Cited by 258
Pyruvate Kinase Isoform Expression Alters Nucleotide Synthesis to Impact Cell Proliferation
Lunt, S. Y., Muralidhar, V., Hosios, A. M., Israelsen, W. J., Gui, D. Y., Newhouse, L., Ogrodzinski, M., Hecht, V., Xu, K., Acevedo, P. N. M., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2014.10.027 · Cited by 257
Measuring lymphocyte proliferation, survival and differentiation using CFSE time-series data
Hawkins, E. D., Hommel, M., Turner, M. L., Battye, F. L., Markham, J. F., & Hodgkin, P. D. (2007) · Nature Protocols · doi:10.1038/nprot.2007.297 · Cited by 250
Multiple sclerosis animal models: a clinical and histopathological perspective
Kipp, M., Nyamoya, S., Hochstrasser, T., & Amor, S. (2017) · Brain Pathology · doi:10.1111/bpa.12454 · Cited by 226
snakePipes: facilitating flexible, scalable and integrative epigenomic analysis
Bhardwaj, V., Heyne, S., Sikora, K., Rabbani, L., Rauer, M., Kilpert, F., Richter, A. S., Ryan, D. P., & Manke, T. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz436 · Cited by 196
Cao, Y., Rathmell, J. C., & Macintyre, A. N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104104 · Cited by 177
Aerobic glycolysis and lymphocyte transformation
Hume, D. A., Radik, J. L., Ferber, E., & Weidemann, M. J. (1978) · Biochemical Journal · doi:10.1042/bj1740703 · Cited by 172
The Circadian Clock Controls Immune Checkpoint Pathway in Sepsis
Deng, W., Zhu, S., Zeng, L., Liu, J., Kang, R., Yang, M., Cao, L., Wang, H., Billiar, T. R., Jiang, J., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.026 · Cited by 172
Posttranslational Modifications of Pyruvate Kinase M2: Tweaks that Benefit Cancer
Prakasam, G., Iqbal, M. A., Bamezai, R. N. K., & Mazurek, S. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00022 · Cited by 161
Loss of the molecular clock in myeloid cells exacerbates T cell-mediated CNS autoimmune disease
Sutton, C. E., Finlay, C. M., Raverdeau, M., Early, J. O., DeCourcey, J., Zasłona, Z., O'Neill, L. A. J., Mills, K. H. G., & Curtis, A. M. (2017) · Nature Communications · doi:10.1038/s41467-017-02111-0 · Cited by 138
Self-citationT-bet and Eomesodermin Play Critical Roles in Directing T Cell Differentiation to Th1 versus Th17
Yang, Y., Xu, J., Niu, Y., Bromberg, J. S., & Ding, Y. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.12.8700 · Cited by 136
Pyruvate Kinase M2 Activates mTORC1 by Phosphorylating AKT1S1
He, C.-L., Bian, Y., Xue, Y., Liu, Z., Zhou, K.-Q., Yao, C.-F., Lin, Y., Zou, H.-F., Luo, F.-X., Qu, Y.-Y., et al. (2016) · Scientific Reports · doi:10.1038/srep21524 · Cited by 136
Lack of Evidence for PKM2 Protein Kinase Activity
Hosios, A. M., Fiske, B. P., Gui, D. Y., & Heiden, M. G. V. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.07.013 · Cited by 119
Bettencourt, I. A., & Powell, J. D. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601318 · Cited by 111
Pyruvate kinase M2 is requisite for Th1 and Th17 differentiation
Kono, M., Maeda, K., Stocton-Gavanescu, I., Pan, W., Umeda, M., Katsuyama, E., Burbano, C., Orite, S. Y. K., Vukelic, M., Tsokos, M., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.127395 · Cited by 103
Chang, J., Burkett, P. R., Borges, C. M., Kuchroo, V. K., Turka, L. A., & Chang, C. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206048110 · Cited by 93
Lü, S., Deng, J., Liu, H., Liu, B., Yang, J., Miao, Y., Li, J., Wang, N., Jiang, C., Xu, Q., et al. (2018) · Journal of Molecular Medicine · doi:10.1007/s00109-018-1645-6 · Cited by 75
Immunometabolism and autoimmunity
Freitag, J., Berod, L., Kamradt, T., & Sparwasser, T. D. (2016) · Immunology and Cell Biology · doi:10.1038/icb.2016.77 · Cited by 66
IL-1β induced HIF-1α inhibits the differentiation of human FOXP3+ T cells
Feldhoff, L., Rueda, C. M., Moreno‐Fernandez, M. E., Sauer, J., Jackson, C. M., Chougnet, C. A., & Rupp, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-00508-x · Cited by 61
AKT-induced PKM2 phosphorylation signals for IGF-1-stimulated cancer cell growth
Park, Y. S., Kim, D. J., Koo, H., Jang, S. H., You, Y.-M., Cho, J. H., Yang, S., Yu, E. S., Jung, Y., Lee, D. C., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10179 · Cited by 58
Netzker, R., Greiner, E. F., EIGENBRODT, E., Noguchi, T., Tanaka, T., & Brand, K. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42712-3 · Cited by 52
Dichloroacetate alleviates development of collagen II-induced arthritis in female DBA/1 mice
Li, B., Josefsson, E., Jonsson, I., Verdrengh, M., Ohlsson, C., Bokarewa, M. I., Tarkowski, A., & Magnusson, M. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2799 · Cited by 47
Retinoic acid suppresses IL‐17 production and pathogenic activity of γδ T cells in CNS autoimmunity
Raverdeau, M., Breen, C. J., Misiak, A., & Mills, K. H. G. (2016) · Immunology and Cell Biology · doi:10.1038/icb.2016.39 · Cited by 45
Self-citationMarjanovic, S., Skog, S., Heiden, T., Tribukait, B., & Nelson, B. D. (1991) · Experimental Cell Research · doi:10.1016/0014-4827(91)90116-c · Cited by 41
Integrative Phosphoproteomics Links IL-23R Signaling with Metabolic Adaptation in Lymphocytes
Lochmatter, C., Fischer, R., Charles, P. D., Yu, Z., Powrie, F. M., & Kessler, B. M. (2016) · Scientific Reports · doi:10.1038/srep24491 · Cited by 33
Effect of HIF1α on Foxp3 expression in CD4+CD25− T lymphocytes
Wu, J., Cui, H., Zhu, Z., Wang, L., Li, H., & Wang, D. (2014) · Microbiology and Immunology · doi:10.1111/1348-0421.12168 · Cited by 21
Granulocyte-macrophage colony-stimulating factor as a mediator of autoimmunity in multiple sclerosis
Kostić, M. S., Živković, N., Cvetanović, A., & Stojanović, I. R. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.07.002 · Cited by 21
Cited by
Lactate modulation of immune responses in inflammatory versus tumour microenvironments
Certo, M., Tsai, C.-H., Pucino, V., Ho, P.-C., & Mauro, C. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-020-0406-2 · Cited by 924
Amino Assets: How Amino Acids Support Immunity
Kelly, B., & Pearce, E. L. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.06.010 · Cited by 643
Self-citationTargeting immunometabolism as an anti-inflammatory strategy
Pålsson-McDermott, E. M., & O’Neill, L. A. J. (2020) · Cell Research · doi:10.1038/s41422-020-0291-z · Cited by 577
Self-citationThe Role of Inflammation in Diabetic Retinopathy
Forrester, J. V., Kuffova, L., & Delibegovic, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.583687 · Cited by 432
Lactylation of PKM2 Suppresses Inflammatory Metabolic Adaptation in Pro-inflammatory Macrophages
Wang, J., Yang, P., Yu, T., Gao, M., Liu, D., Zhang, J., Lu, C., Chen, X., Zhang, X., & Liu, Y. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.75434 · Cited by 402
Metadata
- Authors
- Angiari, S., Runtsch, M. C., Sutton, C. E., Palsson-McDermott, E. M., Kelly, B., Rana, N., Kane, H., Papadopoulou, G., Pearce, E. L., Mills, K. H. G., & O'Neill, L. A. J.
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2020-02
- Volume
- 31
- Issue
- 2
- Pages
- 391-405.e8
- ISSN
- 1550-4131 (ISSN-L)
- OpenAlex
- W2990172821
- Cited by
- 305
- References
- 59
- FWCI
- 10.01
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.